/TCBP
TCBP Stock - TC Biopharm (Holdings) Plc
Healthcare|BiotechnologyNASDAQ
$0.50+0.00%
+$0.00 (+0.00%) • Mar 21
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.55
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for TCBP
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.49 – $0.51
TARGET (TP)$0.57
STOP LOSS$0.46
RISK/REWARD1:1.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.01
52W High$523.20
52W Low$0.08
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | N/A | $3.84M | $1.98M | $1.98M | $3.43M |
| Gross Profit | N/A | $3.84M | $1.98M | $1.98M | $3.43M |
| Gross Margin | N/A | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Income | $-14,239,323 | $-12,083,997 | $-7,287,024 | $-6,886,739 | $-6,640,542 |
| Net Income | $-5,906,953 | $-1,313,601 | $-13,575,925 | $-5,457,916 | $-6,067,984 |
| Net Margin | N/A | -34.2% | -686.1% | -275.8% | -177.1% |
| EPS | $-9.56 | $-19.12 | $-82488.00 | $-124.00 | $-138.00 |
Company Overview
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
TCBPBeat Rate
50%
Last 2 quarters
Avg Surprise
+0.1%
EPS vs Estimate
Beats / Misses
1/1
Last 12 quarters
Latest EPS
$-0.00
Q4 2024
EPS Surprise History
Q4 22
+100.3%
$0.02vs$-7.00
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q2 24
-100.2%
$-0.02vs$14.00
Q2 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Apr 7, 2025 | — | — | — | — |
Q1 2025 | Feb 26, 2025 | — | — | — | — |
Q4 2024 | Nov 25, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 15, 2024 | — | $-2.80 | — | — |
Q2 2024 | May 6, 2024 | $14.00 | $-0.02 | -100.2% | ✗ MISS |
Q4 2023 | Nov 2, 2023 | — | $0.00 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.02 | — | — |
Q2 2023 | May 1, 2023 | — | $-0.08 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.02 | — | — |
Q4 2022 | Dec 12, 2022 | $-7.00 | $0.02 | +100.3% | ✓ BEAT |
Q3 2022 | Sep 30, 2022 | — | $-0.07 | — | — |
Q2 2022 | May 13, 2022 | — | $-0.67 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.03 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.85 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.16 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.16 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.16 | — | — |
Q3 2020 | Sep 29, 2020 | — | $-0.14 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.16 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.16 | — | — |
Frequently Asked Questions about TCBP
What is TCBP's current stock price?
TC Biopharm (Holdings) Plc (TCBP) is currently trading at $0.50 per share. The stock has moved +0.00% today.
What is the analyst price target for TCBP?
No analyst price targets are currently available for this stock.
What sector is TC Biopharm (Holdings) Plc in?
TC Biopharm (Holdings) Plc operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is TCBP's market cap?
TC Biopharm (Holdings) Plc has a market capitalization of $0.00 billion, making it a small-cap company.
Does TCBP pay dividends?
No, TC Biopharm (Holdings) Plc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBLPH
Bellerophon Therapeutics, Inc.
$0.01
Mkt Cap: $0.0B
HSTO
Histogen Inc.
$0.02
Mkt Cap: $0.0B
IMTX
Immatics N.V.
$10.27
Mkt Cap: $1.2B
LFLY
Leafly Holdings, Inc.
$37.00
Mkt Cap: $0.1B
LSB
LakeShore Biopharma Co., Ltd
$0.63
Mkt Cap: $0.0B
OSA
ProSomnus, Inc.
$0.47
Mkt Cap: $0.0B
PHIO
Phio Pharmaceuticals Corp.
$1.07
Mkt Cap: $0.0B
SEEL
Seelos Therapeutics, Inc.
$0.37
Mkt Cap: $0.0B
TFFP
TFF Pharmaceuticals, Inc.
$0.07
Mkt Cap: $0.0B
VIRI
Virios Therapeutics, Inc.
$0.15
Mkt Cap: $0.0B
Explore stocks similar to TCBP for comparison